| Cat. No. |
CRP08102 |
| Product Overview |
Recombinant murine
VEGF165 produced in E. coli is a 39.0 kDa disulfide-linked
homodimeric protein consisting of two 165 amino acid polypeptide
chains. |
| Description |
VEGF was initially
purified from media conditioned by normal bovine pituitary
folliculo-stellate cells and by a variety of transformed cell lines
as a mitogen specific for vascular endothelial cells. It was
subsequently found to be identical to an independently discovered
vascular permeability factor (VPF), which was previously identified
in media conditioned by tumor cell lines based on its ability to
increase the permeability of capillary blood vessels. Three mouse
cDNA clones, which arise through alternative splicing and which
encode mature mouse monomeric VEGF having 120, 164, or 188, amino
acids, respectively, have been identified. Two receptor tyrosine
kinases (RTKs), Flt-1 and Flk-1 (the mouse homologue of human KDR),
both members of the type III subclass of RTKs containing seven
immunoglobulin-like repeats in their extracellular domains, have
been shown to bind VEGF with high affinity. The roles of the
homodimers of KDR, Flt, and the heterodimer ofKDR/Flt in VEGF signal
transduction remain to be elucidated.In vivo, VEGF has been found to
be a potent angiogenesis inducer. |
| Purity |
>95% by SDS-PAGE and HPLC
analyses. |
| Formulation |
Lyophilized from a
0.2mm filtered solution in PBS, pH 7.4. |
| Endotoxin |
Less than 1EU/mg of rmVEGF165 as
determined by LAL method. |
| Reconstitution |
We recommend that
this vial be briefly centrifuged prior to opening to bring the
contents to the bottom. Reconstitute in sterile distilled water or
aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0
mg/ml. Stock solutions should be apportioned into working aliquots
and stored at <-20°C. Further dilutions should be made in
appropriate buffered solutions. |
| Storage |
This lyophilized preparation is stable for
several weeks at 2-8°C, but should be kept at -20°C for long term
storage, preferably desiccated. Upon reconstitution, the preparation
is stable for up to one week at 2-8°C. For maximal stability,
apportion the reconstituted preparation into working aliquots and
store at -20°C to -70°C. Avoid repeated freeze/thaw cycles. |
| Gene Information |
Gene Name |
VEGF165 |
|
Synonyms |
Vpf; Vegf; Vegf-a;
Vegfa; Vegf120; Vegf164; Vegf188; vascular endothelial growth
factor; vascular endothelial growth factor A; MGC70609; Vascular
endothelial growth factor A precursor; Vascular permeability factor |
|
GeneID |
22339 |
|
mRNA Refseq |
NM_001025250 |
|
Protein Refseq |
NP_001020421 |
|
MIM |
192240 |
|
UniProt ID |
P15692 |
|
Chromosome Location |
17 C; 17 24.2 cM |
|
Pathway |
Cytokine-cytokine receptor interaction;Focal
adhesion ;Pancreatic cancer;Renal cell carcinoma;VEGF signaling
pathway;mTOR signaling pathway . |
|
Function |
growth factor
activity; heparin binding; protein binding growth factor receptor
binding. |
|
.jpg) |
Download Datasheet
 |
|
PDB rendering
based on 1bj1. |
|